Timothy James Rink
Director/Board Member at Kymab Ltd.
Network origin in Timothy James Rink first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
33
| Subsidiary | Pharmaceuticals: Major | 33 |
| Public Company | Pharmaceuticals: Major | 18 | |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.
17
| Foundation/Endowment | Investment Trusts/Mutual Funds | 17 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.
8
| Holding Company | Biotechnology | 8 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.
8
| Extinct | Pharmaceuticals: Major | 8 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Timothy James Rink via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Administrative Officer Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| POZEN INC. | Pharmaceuticals: Major | President Chief Executive Officer Director/Board Member Compliance Officer | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer Corporate Officer/Principal | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Human Resources Officer | |
Wellcome Trust Finance Plc
 Wellcome Trust Finance Plc Finance/Rental/LeasingFinance Part of The Wellcome Trust Ltd., Wellcome Trust Finance Plc works with individuals and organizations to solve health challenges using science. The company is based in London, UK. Wellcome funds research, leads policy and advocacy campaigns, and builds partnerships to improve health for everyone. The British company supports discovery research into life, health, and wellbeing, and are taking on three worldwide health challenges: mental health, climate and health, and infectious diseases. Wellcome provides guidance on applying for funding, starting a grant, research policies, and more. The company also offers advice on ending a grant and managing research outputs. | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Compliance Officer President Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
| Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Birmingham | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Director/Board Member Graduate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Wellcome Trust Investments 1 Unlimited
 Wellcome Trust Investments 1 Unlimited Financial ConglomeratesFinance Part of The Wellcome Trust Ltd., Wellcome Trust Investments 1 Unlimited is a charitable foundation based in London, UK. The British company aims to improve health and save lives by utilizing science's potential. The company provides grant funding opportunities and conduct research on mental health, infectious disease, climate and health, and discovery research. Additionally, they have a free museum called Wellcome Collection that explores health and human experience. The company also advocates for improving health for everyone through their monthly newsletter and other events. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Wellcome Trust Investments 2 Unlimited
 Wellcome Trust Investments 2 Unlimited Other Consumer ServicesConsumer Services Part of The Wellcome Trust Ltd., Wellcome Trust Investments 2 Unlimited is a charitable foundation that exists to improve health for everyone by supporting discovery research into life, health, and wellbeing. The company is based in London, UK and is taking on three worldwide health challenges: mental health, climate and health, and infectious diseases. The British company's investments portfolio and investments team are also highlighted in the company's description. Founded in 2008, the company's vision and strategy focus on preventing climate change from getting worse and protecting the communities most at risk. | Other Consumer Services | Director/Board Member Director/Board Member | |
Wellcome Trust Residential 1 Ltd.
 Wellcome Trust Residential 1 Ltd. Real Estate Investment TrustsFinance Part of The Wellcome Trust Ltd., Wellcome Trust Residential 1 Ltd. is a real estate investment trust. The company is based in London, UK. Founded in 2007. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Wellcome Trust Residential 2 Ltd.
 Wellcome Trust Residential 2 Ltd. Real Estate Investment TrustsFinance Part of The Wellcome Trust Ltd., Wellcome Trust Residential 2 Ltd. engages in holding property investment. The company is based in London, UK. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Gower Place Investments Ltd.
 Gower Place Investments Ltd. Financial ConglomeratesFinance Part of The Wellcome Trust Ltd., Gower Place Investments Ltd. is a British company that engages in investment activities. The company is based in London, UK and was founded in 2013. | Financial Conglomerates | Director/Board Member Director/Board Member | |
The Wellcome Trust Ltd. (Investment Management)
 The Wellcome Trust Ltd. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. (Investment Management) (Wellcome-IM) is the investment management division of The Wellcome Trust Ltd., a politically and financially independent global charitable foundation headquartered in London, UK. The Wellcome Trust was founded in 1936, in accordance with Henry Wellcome’s will, to improve health by supporting scientific research and the study of medicine. Funding for this mission came from the profits of the pharmaceutical business he had built up over 50 years. Wellcome-IM manages The Wellcome Trust. | Investment Trusts/Mutual Funds | Chief Investment Officer Chief Investment Officer | |
Oxstem Ltd.
 Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Executive Officer Founder | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Director/Board Member | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | President Chief Executive Officer Compliance Officer |
Statistics
International
| United States | 28 |
| United Kingdom | 15 |
| Germany | 4 |
| Sweden | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 436 |
| Corporate Officer/Principal | 226 |
| Chairman | 108 |
| Independent Dir/Board Member | 97 |
| Chief Executive Officer | 76 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel Bradbury | 45 |
| Alf Gunnar Martin Nicklasson | 31 |
| Kleanthis Xanthopoulos | 29 |
| Hans-Peter Hasler | 28 |
| John Mendlein | 27 |
| Mark Iwicki | 26 |
| Timothy Barberich | 26 |
| Stuart J. M. Collinson | 25 |
| Michael Lytton | 24 |
| Danny Truell | 23 |
| Bernd Seizinger | 23 |
| Joe C. Cook | 23 |
| Robert J. Cresci | 22 |
| William Castell | 22 |
| David Southwell | 19 |
- Stock Market
- Insiders
- Timothy James Rink
- Company connections
